STAGE IV RENAL CELL CANCER
Clinical trials for STAGE IV RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for advanced kidney cancer
Disease control OngoingThis study tested two drugs, pazopanib and bevacizumab, given in turns to people with advanced kidney cancer that had spread. The goal was to find the best dose and see if the combination could control tumor growth. 51 patients took part, and the study focused on safety and how l…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
New combo therapy aims to boost immune attack on kidney cancer
Disease control OngoingThis study tests whether adding an experimental drug (anti-OX40 antibody) to a standard targeted therapy (axitinib) can help control advanced kidney cancer that has spread. About 62 adults whose cancer worsened after prior immunotherapy will receive either the combination or axit…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called ceralasertib, either alone or combined with olaparib or durvalumab, in people with advanced solid tumors like kidney, bladder, pancreatic, endometrial, and prostate cancers. The goal is to see if these combinations can shrink tumors or slow their gr…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated May 18, 2026 11:59 UTC